$175M Shareholder Derivative Settlement With Opioid Seller Gains Final Approval
Mealey's (April 23, 2020, 1:54 PM EDT) -- OAKLAND, Calif. — A federal judge in California on April 22 granted final approval to a $175 million shareholder derivative settlement with opioid drug distributor McKesson Corp. stemming from allegations that...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login